Delta
variant behind more than 80% of U.S. cases; vaccines still highly
effective -Fauci
Send a link to a friend
[July 21, 2021]
By Carl O'Donnell and Mrinalika Roy
(Reuters) -The Delta variant of the
coronavirus is the cause of more than 80% of new U.S. COVID-19 cases,
but the authorized vaccines remain more than 90% effective in preventing
hospitalizations and deaths, said top U.S. infectious disease expert
Anthony Fauci during U.S. Senate hearing on Tuesday.
|
The hearing featured a pointed exchange with Republican U.S. Senator
Rand Paul, in which he accused Fauci of lying about the National
Institutes of Health providing funding for research at China's Wuhan
Institute of Virology.
The Senator from Kentucky, who has sparred with Fauci during several
pandemic-related hearings, alleged that the research may have played
a role in developing the novel coronavirus at the Wuhan Lab.
"If caught lying to Congress... the U.S. criminal code creates a
felony and a five year penalty," Paul said to Fauci during the
hearing.
Fauci, who has been mostly calm and diplomatic in past responses,
this time shot back: "Senator Paul, I have never lied before the
Congress... (and) you do not know what you're talking about." The
exchange featured raised voices and pointed fingers.
The origin of the novel coronavirus has become a heated partisan
issue in the United States, with Republicans urging further
inquiries into whether it was developed in a laboratory in Wuhan,
China.
Biden in late May called on aides to investigate the origins of the
virus and to report back to him within 90 days. The more prevalent
theory is that the virus originated in animals, possibly bats, and
was passed on to humans.
The more contagious Delta variant was first found in India earlier
this year. It has since become the dominant version of the virus in
the United States and many other countries. It has been detected in
more than 90 nations worldwide.
[to top of second column] |
Deaths from COVID-19 in the
United States have averaged 239 per day over the
past week, nearly 48% higher than the previous
week, U.S. Centers for Disease Control and
Prevention (CDC)Director Rochelle Walensky said
during the hearing. States
should continue to hold onto their inventories of unused vaccines as
manufacturers are working to determine the shelf life of their
shots, Janet Woodcock, the acting director of the U.S. Food and Drug
Administration, said during the hearing. Large quantities of unused
U.S. vaccine supplies are facing expiration in the coming weeks if
the shelf life is not extended.
The CDC is reviewing data from multiple groups of vaccinated people
to determine how long protection from COVID-19 shots lasts and will
use that information to make a determination on the potential role
of additional booster shots, Fauci said.
(Reporting by Carl O'Donnell in New York and Mrinalika Roy in
Bengaluru; Editing by Bill Berkrot)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
|